Position in GILD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$231,581
-$21,933 QoQ
Shares Held
1,833
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,834
of 2,265 holders
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nicholas Hoffman & Company, LLC. holds $35,503,201 across 12 Drug Manufacturers - General names. GILD ranks #12 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,776 | $11,725,628 | |
| 2 | JNJ |
Johnson & Johnson
|
34,137 | $8,669,773 | |
| 3 | ABBV |
AbbVie Inc.
|
10,274 | $2,585,349 | |
| 4 | AZN |
Astrazeneca PLC
|
11,897 | $2,255,909 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
35,055 | $2,019,869 | |
| 6 | GSK |
GSK plc
|
37,580 | $1,969,943 | |
| 7 | MRK |
Merck & Co., Inc.
|
15,146 | $1,946,261 | |
| 8 | NVS |
Novartis AG
|
9,771 | $1,531,311 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $231,581 | 1,833 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $253,514 | 1,819 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $223,264 | 1,819 | Shares | Sole | 2026-02-02 | |
| 2024-06-30 | $300,992 | 4,387 | Shares | Sole | 2024-08-02 | |
| No filing history on record for this holder in this stock. | ||||||